P&G HR chief granted 12,336 stock options
Procter & Gamble’s Chief Human Resources Officer received a new option grant covering 12,336 shares at a $146.67 exercise price.
Rhea-AI Filing Summary
PROCTER & GAMBLE Co (PG) reported that Chief Human Resources Officer Purushothaman Balaji received a grant of 12,336 stock options on September 15, 2026. The options carry an exercise price of $146.67 per share and are scheduled to become exercisable on September 14, 2029, expiring on September 15, 2036. After this grant, Balaji holds these 12,336 options directly, along with 15,476.7953 shares of common stock directly and 5,820.1949 shares indirectly through a retirement plan trustee. No Rule 10b5-1 trading plan is reported.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 12,336 shares
Grant/Award
3 txns
Insider
Purushothaman Balaji
Role
Chief Human Resources Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 12,336 | $0.00 | $0.00 |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 12,336 contracts (Direct);
Common Stock — 15,476.7953 shares (Direct);
Common Stock — 5,820.1949 shares (Indirect, By Retirement Plan Trustee)
Key Figures
Stock options granted: 12,336 options
Exercise price: $146.67 per share
Option vesting (exercise) date: September 14, 2029
+4 more
7 metrics
Stock options granted
12,336 options
Grant to Chief Human Resources Officer on September 15, 2026
Exercise price
$146.67 per share
Exercise price of stock options granted September 15, 2026
Option vesting (exercise) date
September 14, 2029
Scheduled exercise date for granted options
Option expiration date
September 15, 2036
Expiration of granted stock options
Direct common stock holdings
15,476.7953 shares
Common stock directly held after reported transactions
Indirect common stock holdings
5,820.1949 shares
Common stock held indirectly by Retirement Plan Trustee
Options held after grant
12,336 options
Total stock options directly held after the grant
Key Terms
Stock Option (Right to Buy), exercise price, expiration date
3 terms
Stock Option (Right to Buy) financial
"The security title is listed as Stock Option (Right to Buy)."
exercise price financial
"The options carry an exercise price of $146.67 per share."
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"The options have an expiration date of September 15, 2036."
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did PG report for Purushothaman Balaji on September 15, 2026?
PG reported that Chief Human Resources Officer Purushothaman Balaji received a grant of 12,336 stock options on September 15, 2026, as a compensation-related award, with no shares sold in this filing.
What is the exercise price of the new stock options granted to PG executive Purushothaman Balaji?
The newly granted stock options to Purushothaman Balaji have an exercise price of $146.67 per share, meaning he can buy Procter & Gamble common stock at that price once the options become exercisable.
When do Purushothaman Balaji’s new PG stock options vest and expire?
The stock options granted to Purushothaman Balaji are scheduled to become exercisable on September 14, 2029 and will expire on September 15, 2036, if not exercised earlier.
Were the reported PG insider transactions made under a Rule 10b5-1 trading plan?
No. The filing indicates that no Rule 10b5-1 trading plan is reported for these transactions, meaning the option grant and reported holdings are not identified as being made under a pre-arranged trading plan.
AI-generated analysis. How Rhea-AI works. Not financial advice.
